Compounds > carbenicillin
Page last updated: 2024-08-22

carbenicillin and ro13-9904

carbenicillin has been researched along with ro13-9904 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Livermore, DM; Yang, YJ1
Livermore, DM; Williams, JD; Williams, RJ1
Asphaug Kjellevold, V; Dibb, WL; Digranes, A1
Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F1

Other Studies

4 other study(ies) available for carbenicillin and ro13-9904

ArticleYear
Beta-lactamase lability and inducer power of newer beta-lactam antibiotics in relation to their activity against beta-lactamase-inducibility mutants of Pseudomonas aeruginosa.
    The Journal of infectious diseases, 1987, Volume: 155, Issue:4

    Topics: Anti-Bacterial Agents; Azlocillin; beta-Lactamases; Carbenicillin; Cefotaxime; Ceftriaxone; Enzyme Induction; Imipenem; Kinetics; Mutation; Pseudomonas aeruginosa; Thienamycins

1987
Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 1981, Volume: 8, Issue:4

    Topics: beta-Lactamases; Carbenicillin; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa

1981
Pseudomonas aeruginosa and Acinetobacter calcoaceticus: in vitro susceptibility of 150 clinical isolates to five beta-lactam antibiotics and tobramycin.
    Chemotherapy, 1983, Volume: 29, Issue:5

    Topics: Acinetobacter; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Ceftriaxone; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Tobramycin

1983
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
    Burns : journal of the International Society for Burn Injuries, 2016, Volume: 42, Issue:1

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection

2016